16 results
8-K
EX-3.1
ATRS
Antares Pharma, Inc.
24 May 22
Entry into a Material Definitive Agreement
4:22pm
8-K
EX-3.2
ATRS
Antares Pharma, Inc.
24 May 22
Entry into a Material Definitive Agreement
4:22pm
SC14D9C
EX-3.1
ATRS
Antares Pharma, Inc.
13 Apr 22
Written communication relating to third party tender offer
12:30pm
8-K
EX-3.1
ATRS
Antares Pharma, Inc.
13 Apr 22
Halozyme to Acquire Antares Pharma to Create a Specialty Product and Drug Delivery Leader
9:21am
8-K
EX-3.1
ATRS
Antares Pharma, Inc.
28 May 13
Departure of Directors or Certain Officers
12:00am
8-K
EX-3
7vg6hhz s5wujofo1e
19 May 08
Entry into a Material Definitive Agreement
12:00am
8-K
EX-3
fz8uwm4i6ryu 6a
15 May 07
Other Events
12:00am
10-K405
EX-3.1
a4ab1xsrglf
16 Apr 01
Annual report (delinquent filer disclosure)
12:00am
10-K405
EX-3.5
hj36 2r7ztae
16 Apr 01
Annual report (delinquent filer disclosure)
12:00am
10-K405
EX-3.3
i9471nyn 4mews92
31 Mar 99
Annual report (delinquent filer disclosure)
12:00am
S-1/A
EX-3.4
wxtlzdqiqzhcd ac3j
15 Aug 96
IPO registration (amended)
12:00am
S-1/A
EX-3.3
uset xsnu3yqr
15 Aug 96
IPO registration (amended)
12:00am
S-1
EX-3.1
bgfkz6qm10lw4
24 Jun 96
IPO registration
12:00am
S-1
EX-3.2
v2nqefmmtgl4j5ggwz
24 Jun 96
IPO registration
12:00am
- Prev
- 1
- Next